Skip to Main Content
Skip Nav Destination

Medical Cannabis and Cannabinoids


Editor: Vrana, K.E. (Hershey, PA, USA)

Editorial Board

Submit manuscript

Medical Cannabis and Cannabinoids is an international, open-access, peer-reviewed journal dedicated to exploring all aspects of the medical uses of cannabis and cannabinoids, and all secondary metabolites from Cannabis sativa L. This includes:

  • Basic science concerning the underlying pharmacological aspects of the cannabis plant and its compounds, mechanisms of action, the endocannabinoid system, phytocannabinoids, synthetic cannabinoids, terpenes, and flavonoids
  • Pre-clinical and clinical studies on indications and use of cannabis and cannabinoids in the treatment of disease and medical conditions
  • Potential hazards, harms, and concerns around the use of medicinal cannabis
  • Public policy forum, including legal and regulatory considerations
  • Well-controlled prospective and retrospective studies of cannabis efficacy used in medical and treatment settings

 

The journal accepts original research, reviews, systematic reviews, case reports, brief reports, study protocols, methods papers, and letters. Karger Publishers is interested in both data showing potential efficacy as well as negative results. The journal covers a wide range of topics, including:

  • Indications (and contraindications) for the use of cannabis and cannabis-derived compounds to treat diseases and medical conditions
  • Pharmacological aspects, including: drug development, drug safety, dosage, and toxicology
  • Psychological and psychiatric indications and concerns
  • Public health, epidemiology, and socioeconomic aspects of cannabis and cannabis products
  • Ethnobotany

 

About this Journal

Call for Papers

Minor Cannabinoids and Terpenes in Medical Cannabis: Unlocking the Potential
Submission Deadline: September 30, 2025

CHECK OUT NOW

Journal Details

Editors and Reviewers

Login to our peer review system.

Affiliations

News & Highlights


Karger Image Explorer

Unlock visual excellence with Karger Image Explorer, featuring over 260,000 peer-reviewed images from our esteemed journals. Easily find high-quality visuals, obtain licensing information and request reuse permissions to achieve your goals quickly and efficiently.

Explore Now

Research Viewpoints


Research Viewpoints

Discover highlights from the latest scientific research, interviews with leading scientists, the latest developments from Karger and across the publishing industry in our research blog.

Explore Now



CCORC 2025: Call for Abstracts and Session Proposals

Submission Deadline: February 19, 2025, 11:59 PM EST

The Consortium for Medical Marijuana Clinical Outcomes Research is now accepting abstracts and session proposal submissions for the fifth annual Cannabis Clinical Outcomes Research Conference (CCORC) on May 29-30, 2025.

All submissions will be peer-reviewed and top abstracts will be invited for oral presentations. All abstracts accepted by the conference will be published in Medical Cannabis and Cannabinoids.

Abstracts and posters submitted by students will be considered for awards presented on the final day of the conference. Student presenters from Consortium member universities are eligible to apply for travel support.

Please reach out to [email protected] with any questions.

More Information

Banner IMCCB-25

IMCCB-25

Building on the success of previous Swiss cannabis congresses, IMCCB-25 aspires to bring together a diverse assembly of leading researchers, clinicians, industry professionals, and other experts and opinion leaders from around the world. The conference takes place at the University of Bern, Switzerland, February 13–14, 2025.

More Information

Logo CANNabinoid Drug Interaction Review

New Tool for Evaluating Potential Drug-Drug Interactions Based on Cannabinoids

CANNabinoid Drug Interaction Review (CANN-DIR®), developed at Penn State College of Medicine, is intended to evaluate for potential drug-drug interactions based on the cannabinoids (THC & CBD) affecting the metabolism of OTHER concomitantly prescribed medications. This tool has been developed for use by healthcare providers, patients, caregivers, and interested community members. Medical Cannabis and Cannabinoids has published a product review on this tool: Drug Interaction Review (CANN-DIR), utilizing research published in the review Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions, appearing earlier in the journal.

Try the tool

Congress Announcements

Have a look at all events related to this journal.

View more

Issues & Articles

Connect with Us

Follow us on LinkedIn
Karger │ Research Hub

Check out our LinkedIn Page.

Follow us

Follow us on X
@ResearchKarger

Check out our X feed.

Follow us

Stay Up-to-Date

Get news according to your interests.

SUBSCRIBE NOW

Recommend this Journal

Suggest this journal via social media or e-mail to your colleagues.

Suggest this journal on X (formerly Twitter) Suggest this journal on Facebook Suggest this journal on LinkedIn Suggest this journal via E-mail

or Create an Account

Close Modal
Close Modal